🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Bankrupt Envision Healthcare approved to split in two, cut debt

Published 10/11/2023, 04:41 PM
Updated 10/11/2023, 05:50 PM
© Reuters.
EVH
-

By Dietrich Knauth

NEW YORK (Reuters) -Envision Healthcare, a provider of outsourced emergency department services to hospitals that is backed by private equity firm KKR, received U.S. bankruptcy court approval on Wednesday to split into two companies and cut over $7 billion in debt.

U.S. Bankruptcy Judge Christopher Lopez approved Envision's restructuring at a court hearing in Houston. Lopez commended Envision's bankruptcy lawyers for putting together an "incredibly complex" financial transaction while minimizing disruption to patients needing emergency care and the more than 20,000 doctors employed by Envision.

"This is going to remain a viable business and those people have not been forgotten," Lopez said.

The bankruptcy restructuring will split Envision Healthcare into two separate companies, Envision Physician Services (EVPS) and AMSURG.

EVPS will focus on providing doctors to hospital emergency rooms, intensive care units and birthing suites, while AMSURG will operate outpatient surgery centers specializing in gastroenterology, ophthalmology and orthopedic care.

KKR, which acquired the company in a 2018 buyout valued at $10 billion, will lose ownership when the restructuring is complete. AMSURG and EVPS will then be owned by different groups of lenders that provided separate pre-bankruptcy loans to the two businesses. Asset managers Blackstone (NYSE:BX) and Brigade Capital will be among AMSURG's new owners, according to court filings.

After the restructuring, AMSURG will have $1.875 billion in debt and approximately $1.675 billion in equity value, according to bankruptcy court filings. EVPS will have $250 million in debt and approximately $550 million in equity value.

The company filed for bankruptcy in May, saying its high debt was unsustainable due to rising interest rates, high labor costs and payment disputes with health insurers.

© Reuters. U.S. one dollar banknotes are seen in this illustration taken February 8, 2021. REUTERS/Dado Ruvic/Illustration

Envision had said its financial problems were exacerbated by the recent U.S. ban on "surprise" medical bills. These are typically sent to patients who unwittingly receive treatment from an out-of-network doctor, despite visiting a hospital or other medical facility that is in-network for their insurance.

Envision said in bankruptcy court filings that the "surprise billing" ban had unintentionally emboldened insurers in reimbursement negotiations, causing some to unilaterally refuse or delay payment for medical care after it was provided.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.